Stay updated on Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page.

Latest updates to the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the expected study details and navigation. This indicates an access issue rather than a substantive update to the study information.SummaryDifference18%

- Check37 days agoChange DetectedAdded '2017 ( U.S. NIH Grant/Contract )' to the study's Other Study ID Numbers, clarifying funding attribution for the trial. Updated the site revision information by adding 'Revision: v3.6.6' and removing 'Revision: v3.6.5' from the footer, reflecting a platform update.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous v3.6.4, indicating a minor site update. The study information and visible content remain unchanged.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page footer Revision text changes from v3.6.3 to v3.6.4, indicating a new build release.SummaryDifference0.1%

- Check94 days agoChange DetectedThe page shows a new revision label, updating from v3.6.2 to v3.6.3. This indicates a minor site update rather than a change to study content.SummaryDifference0.1%

- Check101 days agoChange DetectedThe page footer now shows Revision: v3.6.2 instead of v3.6.0, indicating a newer build of the page. This reflects an update to the site's underlying code rather than any change to study information.SummaryDifference0.1%

Stay in the know with updates to Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page.